Ind-Swift Laboratories Q2 Results FY27: Standalone PAT Jumps 254.22% to Rs 31.03 Cr
- October 29, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Ind-Swift Laboratories Q2 Results FY27 were declared on 29 October 2026, and the standalone quarterly results show revenue of Rs 234.89 Cr against Rs 156.43 Cr a year earlier, a YoY growth of 50.16%. Net profit was Rs 31.03 Cr against Rs 8.76 Cr in the same quarter last year, up 254.22%. Operating profit also rose, to Rs 42.33 Cr from Rs 8.19 Cr.
Ind-Swift Laboratories Ltd (INDSWFTLAB) Q2 Results FY27 announced on 29 October 2026, covering the company’s standalone financial performance for the July to September quarter. The company reported revenue of Rs 234.89 Cr and net profit of Rs 31.03 Cr. Ind-Swift Laboratories Q2 Results FY27 are placed here against the same quarter last year, with the results date and the YoY comparison shown together on NSE and BSE.
This Ind-Swift Laboratories Q2 Results results analysis walks through the standalone financial highlights, the business drivers, the outlook and the risks. The results analysis begins with the table of revenue, operating profit and net profit, so the headline figures sit in one place before each section adds detail.
Click Here – Get Free Investment Predictions
Ind-Swift Laboratories Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 234.89 Cr | Rs 156.43 Cr | +50.16% YoY |
| Operating Profit | Rs 42.33 Cr | Rs 8.19 Cr | +416.85% YoY |
| Net Profit (PAT) | Rs 31.03 Cr | Rs 8.76 Cr | +254.22% YoY |
Source: company filing for Ind-Swift Laboratories Q2 Results FY27, 29 October 2026. Figures in Rs Crore, Standalone basis.
Key Takeaways from Ind-Swift Laboratories Q2 Results: What Stands Out
- Standalone revenue of Rs 234.89 Cr rose 50.16% from Rs 156.43 Cr in the same quarter last year, a strong YoY growth figure.
- Operating profit of Rs 42.33 Cr compares with Rs 8.19 Cr a year ago, an increase of 416.85% in the middle profit line.
- Net profit of Rs 31.03 Cr compares with Rs 8.76 Cr a year ago, an increase of 254.22% in the bottom line.
- Net profit margin of 13.2% improved from 5.6% in the comparison quarter, so profit grew much faster than revenue.
- Ind-Swift Laboratories Q2 Results FY27 are analysed next, starting with how the three headline lines moved together.
Ind-Swift Laboratories Q2 Results FY27: Performance Analysis
Ind-Swift Laboratories Q2 Results FY27 show that revenue, operating profit and net profit all moved sharply higher on a standalone basis. Ind-Swift Laboratories reported revenue of Rs 234.89 Cr, up 50.16% YoY from Rs 156.43 Cr, and net profit of Rs 31.03 Cr, up 254.22% from Rs 8.76 Cr. These quarterly results place all three lines on a clear upward path.
Revenue added Rs 78.46 Cr over the year, which is the YoY growth in absolute terms, while net profit added Rs 22.27 Cr. Operating profit reached Rs 42.33 Cr against Rs 8.19 Cr, so the middle profit line expanded by more than five times. The supplied figures confirm what changed but do not establish the specific cause, so the disclosed drivers follow separately.
Net profit margin improved to 13.2% from 5.6% in the comparison quarter, which explains why net profit grew faster than revenue. Ind-Swift Laboratories Q2 Results therefore show profit growing well ahead of the top line, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The results analysis starts with revenue, which grew 50.2% year on year to Rs 234.89 Cr in the latest quarter. Ind-Swift Laboratories Q2 Results FY27 show this top-line gain feeding into a much higher profit line.
Net Profit Growth – Net profit rose 254.2% year on year to Rs 31.03 Cr. This is the factor that separates the bottom line from the top line in the quarterly results, with profit growth running far ahead of revenue growth.
Margin Improvement – Net profit margin improved to 13.2% from 5.6% in the comparison quarter. A wider margin means more of each rupee of revenue reached the bottom line.
Low Debt – The company is almost debt free, with a debt-to-assets ratio of 0.01 in FY26. A balance sheet with so little debt leaves the standalone profit exposed to fewer financing costs.
FY27 Outlook After Ind-Swift Laboratories Q2 Results
FY27 full-year results will depend on the quarters that follow and on the sector conditions disclosed over the year. Ind-Swift Laboratories Q2 Results FY27 give one data point for the year, with standalone net profit of Rs 31.03 Cr on revenue of Rs 234.89 Cr, and the remaining quarterly results will complete the picture.
A fuller results analysis of FY27 will need the next quarter alongside this one. Quarterly net profit has ranged from Rs 8.76 Cr to Rs 31.03 Cr over the last five quarters, so the latest quarter sits at the top of that range, which leads directly into the risks below. The Univest Screener can be used to follow the next quarterly results release.
Key Risks to Watch After Ind-Swift Laboratories Q2 Results FY27
Low Return on Equity
Return on equity was low at 3.47% in FY26. Ind-Swift Laboratories Q2 Results FY27 show strong quarterly profit, but the annual ratio is still modest and should be read with that in mind.
Modest Return on Capital Employed
Return on capital employed was modest at 4.00% in FY26. The annual ratio sits well below the pace of growth in the latest quarter.
Volatile Quarterly Net Profit
Quarterly net profit has been volatile, ranging from Rs 8.76 Cr to Rs 31.03 Cr over the last 5 quarters. The YoY growth of 254.22% should be read with that wide range.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Ind-Swift Laboratories Q2 Results FY27 show standalone revenue of Rs 234.89 Cr, up 50.16% YoY, and net profit of Rs 31.03 Cr, up 254.22%. These quarterly results show profit growing far faster than revenue. In short, Ind-Swift Laboratories Q2 Results are best read with the next quarter in view, and investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Ind-Swift Laboratories Q2 Results FY27
What are Ind-Swift Laboratories Q2 Results FY27?
Ans. The standalone quarterly results cover July to September 2026 for Ind-Swift Laboratories, with revenue of Rs 234.89 Cr and net profit of Rs 31.03 Cr, so the headline numbers appear in the Financial Highlights section.
What is the results date for Ind-Swift Laboratories Q2 Results FY27?
Ans. Ind-Swift Laboratories declared its Q2 FY27 results on 29 October 2026, which means the results date falls right after the quarter ended in September, as covered in the opening section.
What revenue was reported in Ind-Swift Laboratories Q2 Results FY27?
Ans. Ind-Swift Laboratories reported standalone revenue of Rs 234.89 Cr for the quarter, compared with Rs 156.43 Cr a year earlier, so the Financial Highlights table places it alongside the prior year.
What net profit was reported in Ind-Swift Laboratories Q2 Results FY27?
Ans. Standalone net profit stood at Rs 31.03 Cr against Rs 8.76 Cr in the same quarter last year, which means the bottom line grew sharply, as the Performance Analysis section explains.
What was the operating profit in Ind-Swift Laboratories Q2 Results FY27?
Ans. Operating profit was Rs 42.33 Cr against Rs 8.19 Cr in the same quarter last year, a rise of 416.85%, and the Financial Highlights table lists it between revenue and net profit.
How much YoY growth did revenue show in Ind-Swift Laboratories Q2 Results FY27?
Ans. Revenue showed YoY growth of 50.16% to Rs 234.89 Cr, while net profit grew faster at 254.22%, a contrast the Performance Analysis section examines in more detail.
Did net profit rise or fall in Ind-Swift Laboratories Q2 Results?
Ans. Net profit rose 254.22% year on year to Rs 31.03 Cr in Ind-Swift Laboratories Q2 Results, and the Key Takeaways section lists this alongside the rise in revenue.
What was the net profit margin in Ind-Swift Laboratories Q2 Results FY27?
Ans. Net profit margin improved to 13.2% from 5.6% in the comparison quarter, which means more of each rupee of revenue reached the bottom line, as the Key Business Factors section notes.
What business factors shaped Ind-Swift Laboratories Q2 Results FY27?
Ans. Revenue growth of 50.2%, net profit growth of 254.2%, a better margin and very low debt are the disclosed factors, and the Key Business Factors section covers each of them.
What are the key risks after Ind-Swift Laboratories Q2 Results FY27?
Ans. The risks are a low return on equity of 3.47%, a modest return on capital employed of 4.00% and volatile quarterly net profit, and the Key Risks section covers each of them.
What is the outlook after Ind-Swift Laboratories Q2 Results?
Ans. FY27 full-year results will depend on the quarters that follow, so the next quarterly results matter, as the Outlook section explains with the net profit range of the last five quarters.
Where can I find the complete Ind-Swift Laboratories Q2 Results FY27 data?
Ans. The Financial Highlights table above carries the revenue, operating profit and net profit figures, while the Univest Screener and Univest app show the wider Ind-Swift Laboratories data in one place, linked from the conclusion.
